MICHELLE NORRIS: Open Payments
NPI 1386903425 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 9 payments from 8 companies in 2025. Trend: 2023 $562 · 2024 $1,118 · 2025 $1,065
Food & beverage: $1,065
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $210 |
| Boston Scientific Corporation | 1 | $144 |
| Lilly USA, LLC | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| MDD US Operations, LLC | 1 | $118 |
| Neurocrine BioSciences, Inc. | 1 | $115 |
| Vanda Pharmaceuticals Inc. | 1 | $115 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
Products named: VRAYLAR, WATCHMAN, ZEPBOUND, CAPLYTA, Qelbree, INGREZZA, FANAPT, REXULTI.
Industry payments across MI — which companies pay providers there.
